Horse ATG in Patients With AA or Low/Int-1 Risk MDS
by on Thursday, June 21st, 2012 | No Comments
Condition: Leukemia
Interventions: Drug: hATG; Drug: Cyclosporine; Drug: Methylprednisone; Drug: Pegfilgrastim; Drug: Filgrastim
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center
Not yet recruiting – verified June 2012
Original post: Horse ATG in Patients With AA or Low/Int-1 Risk MDS